Real-world outcomes of systemic therapy sequencing after earlier-generation EGFR TKI failure in NSCLC with brain metastases.Atulya Aman Khosla, M. Ahluwalia, Rohan Garje et al.|Journal of Clinical Oncology|2026Cited by 0
Continued CNS-penetrant TKI therapy with or without local CNS therapy after brain metastasis diagnosis in NSCLC.Atulya Aman Khosla, M. Ahluwalia, Kevin Zhu et al.|Journal of Clinical Oncology|2026Cited by 0
Renal safety and clinical outcomes of enfortumab vedotin plus pembrolizumab in urothelial carcinoma patients with chronic kidney disease.Parth Dhamelia, Karan Jatwani, Yagnapriya Ammakola et al.|Journal of Clinical Oncology|2026Cited by 0